US 11660318
Use of adipose tissue-derived stromal stem cells in treating fistula
granted A61KA61K35/12A61K35/35
Quick answer
US patent 11660318 (Use of adipose tissue-derived stromal stem cells in treating fistula) held by Takeda Pharmaceutical Company Limited expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K35/12, A61K35/35, A61K45/06, A61P